Home> Products> improved glycemic control

{ "products": [ { "_id": "68b02393f5434d48fca8b8ca", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRELAQWK 50", "description": "TRELAQWK 50 is a modern oral antidiabetic tablet containing Trelagliptin 50 mg, specially developed for adults with type 2 diabetes mellitus. This once-weekly medication helps regulate blood sugar effectively, offering both convenience and strong clinical outcomes. With its advanced formulation, TRELAQWK 50 supports better glycemic control, making it easier for patients to lead a balanced and healthier lifestyle.\nManufactured under strict quality standards, TRELAQWK 50 ensures patient compliance, long-term safety, and efficacy in diabetes management.\nKey Ingredient\nTrelagliptin (50 mg):\nA unique, long-acting DPP-4 (dipeptidyl peptidase-4) inhibitor that allows weekly dosing, ensuring higher treatment adherence while maintaining effective control over blood glucose levels.\nKey Benefits of TRELAQWK 50\nProvides consistent blood sugar management with just one tablet per week\nEnhances insulin secretion while lowering glucagon levels in a glucose-dependent manner\nHelps reduce both fasting and postprandial blood glucose\nConvenient choice for patients with busy schedules who struggle with daily tablets\nLow risk of hypoglycemia when used as monotherapy\nSupports long-term improvement in HbA1c levels\nMechanism of Action – How TRELAQWK 50 Works\nTRELAQWK 50 works by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 and GIP. These incretins are vital for maintaining blood sugar balance. By prolonging incretin activity, trelagliptin:\nStimulates insulin secretion from the pancreas\nReduces glucagon release from alpha cells\nHelps lower blood sugar, particularly after meals\nThis mechanism provides both effective glycemic control and improved patient compliance.\nDirections for Use\nTake one tablet of TRELAQWK 50 once a week, on the same day each week\nCan be taken with or without food\nSwallow whole with a glass of water\nFollow your doctor’s advice for dosage adjustment\nDo not double the dose if missed; consult your healthcare provider\nPossible Side Effects\nTRELAQWK 50 is usually well-tolerated. However, some patients may experience:\nMild headache\nNasopharyngitis (cold-like symptoms)\nDiarrhea\nStomach discomfort or indigestion\nRare allergic reactions (rash, itching)\nIf any unusual or persistent side effects occur, seek medical advice promptly.", "price": 375.0, "discountamount": 112.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2165, "imageuri": "https://productimages.withfloats.com/actual/68b023971624ba892ffd8c69.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b023971624ba892ffd8c69.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-28T09:38:27.036Z", "updatedon": "2025-08-28T09:38:27.036Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-50/2165", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "trelagliptin 50 mg", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6842b8014256f7114dfbd884", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRELAQWK 100", "description": "Trelagliptin 100mg in TRELAQWK 100 is an innovative once-weekly oral medication formulated with Trelagliptin 100mg, specifically designed to support adults in managing type 2 diabetes mellitus (T2DM). As a member of the Dipeptidyl Peptidase-4 (DPP-4) inhibitor class, it provides a simplified and effective approach to improving glycemic control when combined with a healthy diet and regular exercise. Its weekly dosing schedule enhances treatment adherence, offering a more sustainable option for long-term diabetes care.\n\nActive Ingredient:\nTrelagliptin 100mg\nA potent, long-acting DPP-4 inhibitor that helps maintain stable blood glucose levels by preserving incretin activity. Incretins are natural hormones that promote insulin release and suppress glucagon, playing a vital role in blood sugar regulation.\n\nCore Benefits:\nConvenient once-weekly dosing enhances patient compliance\n\nEffectively lowers both fasting and postprandial (after-meal) blood sugar\n\nPromotes natural insulin production without contributing to weight gain\n\nCarries a low risk of hypoglycemia, especially when not used with insulin\n\nCan be used alone or in combination with other antidiabetic medications like metformin or sulfonylureas\n\nMechanism of Action:\nTRELAQWK 100 works by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 and GIP. These hormones play a crucial role in regulating blood sugar after meals. By prolonging their activity, Trelagliptin enhances insulin secretion and reduces glucagon levels, resulting in improved glycemic control. Its extended half-life allows for once-a-week administration, setting it apart from daily DPP-4 inhibitors.\n\nDosage & Administration:\nRecommended Dose: One tablet per week, or as advised by your doctor\n\nHow to Take: With or without food, preferably on the same day each week\n\nIf a dose is missed, do not double the next dose; seek guidance from your healthcare provider\n\nPossible Side Effects:\nTRELAQWK 100 is generally safe and well-tolerated. Some individuals may experience:\n\nHeadache\n\nNasopharyngitis (mild cold symptoms)\n\nConstipation\n\nUpper respiratory tract infections\n\nRare allergic reactions such as rashes or skin irritation\n\nSeek immediate medical advice if you experience unusual symptoms such as severe abdominal pain, persistent skin reactions, or signs of pancreatitis.", "price": 517.0, "discountamount": 155.81, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "medical advice", "generally safe", "healthcare provider", "food preferably", "extended halflife", "crucial role", "dpp4 enzyme", "sulfonylureas mechanism", "antidiabetic medications", "low risk", "vital role", "sustainable option", "regular exercise", "healthy diet", "effective approach", "support adults", "trelaqwk 100trelaqwk 100", "hormones play", "natural hormones", "dose seek guidance", "promote insulin release", "degrades incretin hormones", "experience unusual symptoms", "skin irritation seek", "onceaweek administration setting", "improved glycemic control", "regulating blood sugar", "weight gain carries", "suppress glucagon playing", "improving glycemic control" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2132, "imageuri": "https://productimages.withfloats.com/actual/6842b80c8a53ae8db15a02ac.png", "tileimageuri": "https://productimages.withfloats.com/tile/6842b80c8a53ae8db15a02ac.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-06-06T09:42:25.371Z", "updatedon": "2025-11-18T11:06:40.89Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-100/2132", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Trelagliptin 100mg", "category": "DIABETIC RANGE", "tags": [ "Trelagliptin side effects", "Trelagliptin brand name", "Trelagliptin brands in India", "Trelagliptin uses", "Trelagliptin 100mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "68134d097702eb2332e5ccb0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Gliclazide 40 mg", "description": "GLICLAGLAZE 40 is an oral antidiabetic medication containing Gliclazide 40 mg, formulated to effectively manage Type 2 Diabetes Mellitus. It belongs to the class of drugs known as sulfonylureas, which are specifically designed to control blood glucose levels in adults who cannot manage diabetes through diet and exercise alone. By promoting insulin secretion and improving glycemic control, GLICLAGLAZE 40 helps prevent long-term complications associated with uncontrolled diabetes, such as nerve damage, kidney issues, and cardiovascular diseases.\n\nKey Ingredient\nGliclazide (40 mg):\nGliclazide is a second-generation sulfonylurea, known for its dual effect: stimulating insulin release from the pancreas and offering antioxidant properties. It not only lowers blood sugar but also provides vascular protection, making it suitable for patients at risk of cardiovascular events.\n\nKey Benefits\nEffectively reduces high blood sugar levels in Type 2 diabetes\n\nStimulates natural insulin secretion from pancreatic beta cells\n\nProvides cardiovascular protection by improving endothelial function\n\nMinimizes the risk of microvascular complications like retinopathy and nephropathy\n\nSuitable for long-term glycemic control when lifestyle measures are insufficient\n\nHelps maintain a stable glucose profile throughout the day\n\nHow Does It Work?\nGLICLAGLAZE 40 works by targeting the pancreas to enhance the secretion of insulin, which is essential for lowering blood glucose levels. Gliclazide binds to specific receptors on pancreatic beta cells, triggering the release of insulin in a glucose-dependent manner. This ensures that the medication works primarily when glucose levels are elevated, thus reducing the risk of hypoglycemia compared to older sulfonylureas. Additionally, its antioxidant properties contribute to improved vascular health, protecting blood vessels from oxidative damage often seen in diabetic patients.\n\nDirections for Use\nTake GLICLAGLAZE 40 exactly as prescribed by your healthcare provider\n\nUsually taken once or twice daily, preferably before meals\n\nSwallow the tablet whole with water — do not crush or chew\n\nMaintain a regular schedule for meals and medication to avoid hypoglycemia\n\nMonitor blood glucose levels regularly to track progress\n\nAlways combine with a balanced diet and exercise plan for optimal results\n\nSide Effects\nThough generally well-tolerated, GLICLAGLAZE 40 may cause some side effects:\n\nCommon Side Effects:\n\nHypoglycemia (low blood sugar)\n\nHeadache\n\nDizziness or light-headedness\n\nNausea or stomach discomfort\n\nWeight gain (in some patients)\n\nRare but Serious Side Effects:\n\nLiver enzyme abnormalities\n\nSkin rash or allergic reaction\n\nBlood disorders like anemia or thrombocytopenia\n\nVisual disturbances (usually temporary)\n\nSeek immediate medical attention if symptoms of severe hypoglycemia, such as confusion, fainting, or seizures, occur.", "price": 112.8, "discountamount": 33.84, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "gliclaglaze 40", "exercise plan", "balanced diet", "meals swallow", "nephropathy suitable", "gliclaglaze 40gliclaglaze 40", "seizures occur", "confusion fainting", "severe hypoglycemia", "medical attention", "temporary seek", "patients rare", "lightheadedness nausea", "track progress", "regular schedule", "daily preferably", "healthcare provider", "oxidative damage", "hypoglycemia compared", "glucosedependent manner", "specific receptors", "lifestyle measures", "microvascular complications", "secondgeneration sulfonylurea", "uncontrolled diabetes", "manage diabetes", "specifically designed", "chew maintain", "glucose levels", "cardiovascular protection", "promoting insulin secretion", "diabetic patients directions", "older sulfonylureas additionally", "medication works primarily", "oral antidiabetic medication", "stable glucose profile", "insufficient helps maintain", "vascular protection making", "thrombocytopenia visual disturbances", "antioxidant properties contribute", "longterm glycemic control", "pancreatic beta cells", "lowers blood sugar", "offering antioxidant properties" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2099, "imageuri": "https://productimages.withfloats.com/actual/68134d0b4b698d44a8c316f4.png", "tileimageuri": "https://productimages.withfloats.com/tile/68134d0b4b698d44a8c316f4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-01T10:29:29.141Z", "updatedon": "2025-11-20T07:07:06.869Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gliclazide-40-mg/2099", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Steris Healthcare Pvt Ltd", "category": "DIABETIC RANGE", "tags": [ "Gliclazide 40 mg uses in Hindi", "Gliclazide 40mg brands", "Gliclazide 40 mg price", "Gliclazide 40mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "67a35d815432f8f0afe662b4", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "empagliflozin 25mg+ metformin hydrochloride (extended release) 1000 mg", "description": "GLIEMPAFLOZIN MET ER is a combination medication used to manage type 2 diabetes mellitus (T2DM) by helping control blood sugar levels effectively. It contains two powerful anti-diabetic agents, Empagliflozin and Metformin Hydrochloride (Extended Release), which work together to enhance glucose regulation and reduce the risk of diabetes-related complications. This medication is recommended for patients who require additional glycemic control beyond lifestyle changes and monotherapy treatments.\n\n \nKey Benefits\n \n\n Effective Blood Sugar Control – Helps reduce and maintain optimal blood glucose levels in type 2 diabetic patients.\nWeight Management – Empagliflozin promotes caloric loss through urinary glucose excretion, potentially aiding in weight reduction.\nReduced Risk of Cardiovascular Diseases – Beneficial for heart health, lowering the risk of cardiac complications in diabetic patients.\nInsulin Sensitivity Improvement – Metformin enhances insulin function, reducing insulin resistance.\nLower Risk of Hypoglycemia – A balanced mechanism of action ensures stable blood glucose levels without sudden drops.\nKidney Protection – Empagliflozin may help protect against diabetic nephropathy by reducing kidney stress.\nExtended-Release Formula – Ensures long-lasting blood sugar control with a once-daily dosage for improved patient compliance.\n \nHow Does It Work?\n \n\nEmpagliflozin (SGLT2 Inhibitor) – Blocks the SGLT2 protein in the kidneys, preventing glucose reabsorption and promoting its excretion through urine, thereby reducing blood sugar levels.\nMetformin Hydrochloride (Biguanide) – Reduces glucose production in the liver, enhances insulin response, and delays glucose absorption in the digestive tract.\nTogether, they provide a dual action approach for better glycemic control while minimizing side effects like hypoglycemia.\n \nDirections for Use\n \n\nDosage: Take one tablet per day, preferably with food or as directed by your healthcare provider.\nSwallow whole with a glass of water; do not crush or chew.\n Maintain a healthy diet and follow a regular exercise routine for optimal results.\nRegular monitoring of blood sugar levels is advised.\nDo not stop taking this medication without consulting your doctor.\n\n \nSide Effects:\n \n\nSome individuals may experience mild to moderate side effects, including:\n\nFrequent urination (due to glucose excretion)\nDehydration (increased fluid loss)\nNausea, vomiting, or stomach upset\nDiarrhea or constipation\nMetallic taste in the mouth\nLow blood pressure (Hypotension)\nVitamin B12 deficiency (with long-term use of Metformin)\nUrinary tract infections (UTIs) or genital infections\n Seek medical attention if you experience severe allergic reactions, extreme dizziness, or difficulty breathing.", "price": 245.0, "discountamount": 74.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "combination medication", "hypoglycemia directions", "oncedaily dosage", "difficulty breathing", "experience mild", "stop taking", "healthy diet", "chew maintain", "day preferably", "glycemic control", "digestive tract", "sglt2 protein", "diabetic nephropathy", "balanced mechanism", "cardiac complications", "diabetesrelated complications", "constipation metallic taste", "stomach upset diarrhea", "frequent urination due", "moderate side effects", "doctor side effects", "blood sugar levels", "regular exercise routine", "healthcare provider swallow", "minimizing side effects", "dual action approach", "delays glucose absorption", "improved patient compliance", "heart health lowering", "cardiovascular diseases beneficial", "enhance glucose regulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2049, "imageuri": "https://productimages.withfloats.com/actual/67a35d9d1b599c6f20ba1fa7.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a35d9d1b599c6f20ba1fa7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-05T12:45:53.712Z", "updatedon": "2025-03-27T09:45:21.627Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-25mg-metformin-hydrochloride-extended-release-1000-mg/2049", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN MET ER ", "category": "DIABETIC RANGE", "tags": [ "empagliflozin/metformin 5 mg/1000 mg", "empagliflozin + metformin brand name in india", "empagliflozin + metformin combination brand name", "empagliflozin 12.5 mg+metformin 500 mg price", "Empagliflozin and metformin hydrochloride extended-release tablets", "Empagliflozin and metformin hydrochloride tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "668e77e853fc1c2298508399", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TENELIGOLD PIO 20/15 ", "description": "TENELIGOLD PIO 20/15 \nTeneligliptin & Pioglitazone\nIntroduction\nTENELIGOLD PIO 20/15 combines two antidiabetic medications, Teneligliptin and Pioglitazone, in a single formulation. This combination is designed to manage type 2 diabetes mellitus by targeting different aspects of glucose metabolism, thereby improving glycemic control in patients who are inadequately controlled with monotherapy or require dual therapy.\n\nComposition\n\nTeneligliptin: A dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and reduces glucagon release, thereby lowering blood glucose levels.\nPioglitazone: A thiazolidinedione (TZD) that improves insulin sensitivity in peripheral tissues (muscle and adipose tissue) and reduces hepatic glucose production.\nMechanism of Action\n\nTeneligliptin: Inhibits the degradation of incretin hormones (GLP-1 and GIP), which play a key role in glucose-dependent insulin secretion and suppression of glucagon secretion.\nPioglitazone: Activates peroxisome proliferator-activated receptor gamma (PPAR-γ), leading to improved insulin sensitivity, enhanced glucose uptake in peripheral tissues, and reduced hepatic glucose production.\nIndications\nTENELIGOLD PIO 20/15 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults who are inadequately controlled with diet and exercise alone or with other antidiabetic medications.\nDosage and Administration\n\nThe typical dosage is one tablet of TENELIGOLD PIO 20/15 taken orally once daily, preferably with meals.\nDosage adjustments may be necessary based on individual patient response and tolerability.\nIt is important to adhere to the prescribed dosage regimen to achieve optimal glycemic control.\nSide Effects\nCommon side effects may include:\n\nHypoglycemia (especially when used in combination with insulin or sulfonylureas)\nEdema (fluid retention)\nWeight gain\nHeadache\nNasopharyngitis (common cold)\nMore severe side effects can include:\n\nHeart failure (especially in patients with pre-existing cardiovascular disease)\nHepatic dysfunction (monitor liver function tests periodically)\nBone fractures (especially in women)\nPrecautions\n\nHeart Failure: Use with caution in patients with a history of heart failure or other cardiovascular diseases.\nBladder Cancer: Pioglitazone has been associated with an increased risk of bladder cancer; therefore, it should be used cautiously in patients with a history of bladder cancer or with risk factors.\nLiver Function: Monitor liver function tests before starting treatment and periodically thereafter, as Pioglitazone may cause hepatic dysfunction.\nPregnancy and Lactation: Use during pregnancy and lactation should be avoided unless the potential benefits outweigh the risks.\nDrug Interactions\n\nInsulin/Sulfonylureas: Increased risk of hypoglycemia when used concomitantly with insulin or sulfonylureas.\nGemfibrozil: May increase Pioglitazone levels, requiring dose adjustment.\nCYP2C8 Inhibitors (e.g., Gemfibrozil): May increase Pioglitazone concentrations, necessitating monitoring for adverse effects.\nConclusion\nTENELIGOLD PIO 20/15 offers a dual-action approach to managing type 2 diabetes mellitus by combining Teneligliptin and Pioglitazone. This combination helps improve glycemic control through different mechanisms: enhancing insulin secretion and sensitivity. It is crucial to use this medication under the guidance of a healthcare professional to optimize treatment outcomes while minimizing the risk of side effects. Regular monitoring for efficacy and safety parameters, including blood glucose levels and potential adverse effects, is essential for managing diabetes effectively with TENELIGOLD PIO 20/15.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n", "price": 149.0, "discountamount": 44.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "key role", "one tablet", "Weight gain", "common cold", "risk factors", "dual therapy", "Heart failure", "increased risk", "dosage regimen", "typical dosage", "Bladder Cancer", "Bone fractures", "adipose tissue", "TENELIGOLD PIO", "glucose uptake", "dose adjustment", "fluid retention", "glucagon release", "DPP-4) inhibitor", "safety parameters", "CYP2C8 Inhibitors", "Drug Interactions", "incretin hormones", "different aspects", "Regular monitoring", "treatment outcomes", "Dosage adjustments", "peripheral tissues", "single formulation", "glucagon secretion", "potential benefits", "glucose metabolism", "insulin sensitivity", "Pioglitazone levels", "Hepatic dysfunction", "Common side effects", "different mechanisms", "dual-action approach", "liver function tests", "blood glucose levels", "dipeptidyl peptidase-4", "healthcare professional", "optimal glycemic control", "type 2 diabetes mellitus", "More severe side effects", "potential adverse effects", "hepatic glucose production", "Pioglitazone concentrations", "individual patient response", "two antidiabetic medications", "other cardiovascular diseases", "other antidiabetic medications", "existing cardiovascular disease", "glucose-dependent insulin secretion", "peroxisome proliferator-activated receptor gamma" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1935, "imageuri": "https://productimages.withfloats.com/actual/668e77ebf07c99c3af8e6d67.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e77ebf07c99c3af8e6d67.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T12:00:40.528Z", "updatedon": "2024-07-10T12:00:40.528Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/teneligold-pio-20-15-/1935", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TENELIGOLD PIO 20/15 ", "category": "DIABETIC RANGE", "tags": [ "teneligliptin + pioglitazone brand name", "Zita Plus Pio", "Teneligliptin + Pioglitazone Metformin", "Zita Piomet 1000", "Teneligliptin 20 MG and Pioglitazone 15 MG tablets", "Dapagliflozin", "Zita Piomet 500" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662aa04db100e1fdc2dcb68", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VILDIABATE 100 ", "description": "VILDIABATE 100 \nVildagliptin (100mg)\nVILDIABATE 100 is a medication designed to manage type 2 diabetes mellitus by targeting specific aspects of glucose regulation. It contains Vildagliptin, an oral antidiabetic agent that belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. Vildagliptin works by inhibiting the enzyme DPP-4, which is responsible for degrading incretin hormones like GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide).\n\nHere are key points about VILDIABATE 100:\n\nMechanism of Action: Vildagliptin acts by inhibiting DPP-4, thereby increasing the levels of GLP-1 and GIP. These hormones play crucial roles in glucose metabolism:\n\nGLP-1 stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner. It also inhibits glucagon secretion, reduces appetite, and slows gastric emptying.\nGIP enhances insulin release in response to meals, contributing to postprandial glucose control.\nBlood Sugar Control: By enhancing insulin secretion and reducing glucagon levels, VILDIABATE 100 helps lower blood sugar levels, especially after meals. This mechanism targets both fasting and postprandial hyperglycemia, contributing to overall glycemic control.\n\nDosage and Administration: VILDIABATE 100 is typically taken orally once daily, preferably with a meal to maximize its effects on postprandial glucose levels. The dosage may vary depending on individual needs and response to treatment. It's essential to follow your healthcare provider's instructions regarding dosage and timing.\n\nEfficacy and Safety: Clinical studies have demonstrated the efficacy of Vildagliptin in lowering HbA1c levels (a marker of long-term glucose control) and improving glycemic parameters. It is generally well-tolerated, with common side effects including headache, nasopharyngitis (inflammation of the nose and throat), and upper respiratory tract infections. Serious side effects are rare but may include pancreatitis or hypersensitivity reactions.\n\nCombination Therapy: VILDIABATE 100 may be prescribed as monotherapy or in combination with other antidiabetic medications such as metformin or sulfonylureas. Combining medications with different mechanisms of action can provide synergistic benefits in managing diabetes.\n\nMonitoring and Follow-Up: Regular monitoring of blood sugar levels, kidney function, and other relevant parameters is important during treatment with VILDIABATE 100. Your healthcare provider may adjust the dosage or add/modify other medications based on your response and individual needs.\n\nLifestyle Modifications: In addition to medication, lifestyle modifications such as a healthy diet, regular exercise, weight management, and avoiding tobacco and excessive alcohol intake are essential components of diabetes management.\n\nIn conclusion, VILDIABATE 100 containing Vildagliptin is an effective oral antidiabetic medication that helps regulate blood sugar levels in patients with type 2 diabetes. It acts by enhancing insulin secretion and reducing postprandial glucose levels, contributing to improved glycemic control. However, it should be used under medical supervision, and adherence to prescribed dosage and lifestyle recommendations is crucial for optimal diabetes management.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vildiabate-100-133452\n\n\n\n\n\n", "price": 275.0, "discountamount": 82.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "nose", "GLP-1", "EMAIL", "class", "meals", "Order", "timing", "throat", "enzyme", "Safety", "Dosage", "marker", "tobacco", "fasting", "response", "addition", "appetite", "headache", "patients", "Efficacy", "metformin", "Follow-Up", "adherence", "treatment", "VILDIABATE", "conclusion", "key points", "information", "monotherapy", "healthy diet", "instructions", "sterisonline", "pancreatitis", "inflammation", "sterispharma", "HbA1c levels", "CALL/WHATSAPP", "sulfonylureas", "crucial roles", "Administration", "insulin release", "nasopharyngitis", "kidney function", "glucagon levels", "gastric emptying", "specific aspects", "Clinical studies", "individual needs", "regular exercise", "other medications", "Vildagliptin acts", "incretin hormones", "DPP-4) inhibitors", "weight management", "insulin secretion", "glucose metabolism", "glucose regulation", "glucagon secretion", "blood sugar levels", "Regular monitoring", "Combination Therapy", "glycemic parameters", "common side effects", "Blood Sugar Control", "medical supervision", "healthcare provider", "essential components", "synergistic benefits", "different mechanisms", "Serious side effects", "pancreatic beta cells", "dipeptidyl peptidase-4", "oral antidiabetic agent", "Lifestyle Modifications", "glucose-dependent manner", "excessive alcohol intake", "overall glycemic control", "type 2 diabetes mellitus", "lifestyle recommendations", "other relevant parameters", "long-term glucose control", "hypersensitivity reactions", "postprandial hyperglycemia", "optimal diabetes management", "postprandial glucose levels", "postprandial glucose control", "other antidiabetic medications", "upper respiratory tract infections", "effective oral antidiabetic medication", "glucose-dependent insulinotropic peptide" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1491, "imageuri": "https://productimages.withfloats.com/actual/6662aa0b364f23242470b3ca.png", "tileimageuri": "https://productimages.withfloats.com/tile/6662aa0b364f23242470b3ca.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T06:34:44.056Z", "updatedon": "2024-06-28T11:58:50.164Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/vildiabate-100-/1491", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VILDIABATE 100 ", "category": "DIABETIC RANGE", "tags": [ "VILDIABATE 100", "Vildagliptin (100mg)", "Vildagliptin 100 mg uses", "Vildagliptin 100 mg price", "Vildagliptin 100 mg SR brand Name", "Vildagliptin 100 mg brands in India", "", "Vildagliptin 100 mg generic medicine", "Vildagliptin 100 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6661adf866170d1ff8cb45d2", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TENELIGOLD PM 500 ", "description": "TENELIGOLD PM 500 \nTeneligliptin 20mg, Pioglitazone 15mg & Extended Release Metformin Hydrochloride 500mg\nTENELIGOLD PM 500 is a combination medication containing Teneligliptin, Pioglitazone, and Extended-Release Metformin Hydrochloride. It is primarily prescribed for the management of type 2 diabetes mellitus, a metabolic disorder characterized by high blood sugar levels due to insulin resistance or inadequate insulin production.\n\nTeneligliptin (20mg): Teneligliptin belongs to the dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. It works by inhibiting the DPP-4 enzyme, which enhances the levels of incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These hormones stimulate insulin secretion and inhibit glucagon release, leading to improved glucose control after meals.\n\nPioglitazone (15mg): Pioglitazone is a thiazolidinedione medication that improves insulin sensitivity in muscle and adipose (fat) tissues. It reduces glucose production in the liver and enhances glucose uptake in peripheral tissues. This action helps lower blood sugar levels and improves overall glycemic control.\n\nExtended-Release Metformin Hydrochloride (500mg): Metformin is a biguanide medication that reduces glucose production in the liver, decreases intestinal glucose absorption, and enhances insulin sensitivity in peripheral tissues. Extended-release formulations provide a sustained release of the drug, allowing for once-daily dosing and potentially reducing gastrointestinal side effects.\n\nKey Benefits of TENELIGOLD PM 500:\nComprehensive Glycemic Control: The combination of Teneligliptin, Pioglitazone, and Extended-Release Metformin offers comprehensive control over fasting and postprandial (after-meal) blood sugar levels.\n\nImproved Insulin Sensitivity: Pioglitazone and Metformin work synergistically to improve insulin sensitivity in cells, leading to better utilization of glucose and reduced insulin resistance.\n\nIncretin Hormone Enhancement: Teneligliptin enhances the action of incretin hormones, which regulate insulin secretion and glucagon levels, resulting in improved glucose regulation after meals.\n\nReduced Side Effects: Extended-release formulations of Metformin may reduce gastrointestinal side effects compared to immediate-release formulations.\n\nDosage and Administration:\nThe typical dosage of TENELIGOLD PM 500 is one tablet taken orally once daily, preferably with meals.\nSwallow the tablet whole with a glass of water. Do not crush, chew, or split the tablet unless advised by your healthcare provider.\nFollow your doctor's instructions regarding dosage adjustments based on your medical condition and response to treatment.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/teneligold-pm-500-134300", "price": 180.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "meals", "500mg", "EMAIL", "cells", "drugs", "GLP-1", "liver", "glass", "water", "dosing", "muscle", "action", "doctor", "fasting", "response", "treatment", "management", "one tablet", "utilization", "information", "postprandial", "Pioglitazone", "Key Benefits", "fat) tissues", "sterisonline", "sterispharma", "instructions", "DPP-4 enzyme", "CALL/WHATSAPP", "TENELIGOLD PM", "Teneligliptin", "glucose uptake", "Administration", "typical dosage", "glucose control", "glucagon levels", "glucagon release", "incretin hormones", "insulin secretion", "sustained release", "medical condition", "dosage adjustments", "metabolic disorder", "glucose regulation", "peripheral tissues", "insulin resistance", "glucose production", "healthcare provider", "insulin sensitivity", "biguanide medication", "Reduced Side Effects", "comprehensive control", "combination medication", "DPP-4) inhibitor class", "dipeptidyl peptidase-4", "high blood sugar levels", "overall glycemic control", "type 2 diabetes mellitus", "meal) blood sugar levels", "Incretin Hormone Enhancement", "thiazolidinedione medication", "Extended-release formulations", "inadequate insulin production", "intestinal glucose absorption", "gastrointestinal side effects", "Comprehensive Glycemic Control", "immediate-release formulations", "Extended-Release Metformin Hydrochloride", "glucose-dependent insulinotropic peptide", "Extended Release Metformin Hydrochloride" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1481, "imageuri": "https://productimages.withfloats.com/actual/6661adfd637f8700d7ca4512.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661adfd637f8700d7ca4512.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:39:20.713Z", "updatedon": "2024-06-28T12:21:18.417Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//teneligold-pm-500-/1481", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TENELIGOLD PM 500 ", "category": "DIABETIC RANGE", "tags": [ "TENELIGOLD PM 500", "Teneligliptin 20mg", "Pioglitazone 15mg", "Metformin Hydrochloride 500mg", "Teneligliptin Tablets 20 mg uses", "Teneligliptin 20 mg + Metformin 500", "Teneligliptin 20 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6661ad3166170d1ff8cb4574", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TENELIGOLD PIO 20/15 ", "description": "TENELIGOLD PIO 20/15 \nTeneligliptin & Pioglitazone\nTENELIGOLD PIO 20/15 is a combination medication that contains Teneligliptin and Pioglitazone. It is primarily used in the management of type 2 diabetes mellitus, a condition characterized by high blood sugar levels due to insulin resistance or inadequate insulin production.\n\nTeneligliptin: Teneligliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by inhibiting the DPP-4 enzyme, which in turn enhances the levels of incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These hormones stimulate insulin secretion and inhibit glucagon release, leading to improved glucose control after meals.\n\nPioglitazone: Pioglitazone belongs to the thiazolidinedione class of medications. It works by improving insulin sensitivity in muscle and adipose (fat) tissues, reducing glucose production in the liver, and enhancing glucose uptake in peripheral tissues. This helps lower blood sugar levels and improves overall glycemic control.\n\nBenefits of TENELIGOLD PIO 20/15:\nComprehensive Glycemic Control: The combination of Teneligliptin and Pioglitazone addresses different aspects of glucose metabolism, providing comprehensive control over fasting and postprandial (after-meal) blood sugar levels.\n\nEnhanced Insulin Sensitivity: Pioglitazone improves insulin sensitivity in cells, allowing better utilization of glucose and reducing insulin resistance.\n\nIncretin Hormone Enhancement: Teneligliptin enhances the action of incretin hormones, which regulate insulin secretion and glucagon levels, leading to better glucose regulation after meals.\n\nCardioprotective Effects: Pioglitazone has been associated with cardiovascular benefits such as improved lipid profiles and reduced risk of cardiovascular events in some patients.\n\nHow to Use TENELIGOLD PIO 20/15:\nDosage: The typical dosage is one tablet taken orally once daily, usually with meals. Your healthcare provider will determine the appropriate dosage based on your medical condition and response to treatment.\n\nAdministration: Swallow the tablet whole with a glass of water. Do not crush, chew, or split the tablet unless advised by your doctor.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/teneligold-pio-20-15-134077", "price": 149.0, "discountamount": 44.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "risk", "turn", "Order", "EMAIL", "GLP-1", "water", "glass", "meals", "cells", "liver", "action", "muscle", "doctor", "adipose", "fasting", "patients", "response", "treatment", "one tablet", "management", "information", "medications", "utilization", "Pioglitazone", "postprandial", "fat) tissues", "DPP-4 enzyme", "sterispharma", "sterisonline", "CALL/WHATSAPP", "Teneligliptin", "teneligold-pio", "glucose uptake", "lipid profiles", "typical dosage", "Administration", "TENELIGOLD PIO", "glucagon levels", "glucose control", "glucagon release", "DPP-4) inhibitor", "incretin hormones", "medical condition", "different aspects", "insulin secretion", "glucose production", "insulin resistance", "appropriate dosage", "glucose metabolism", "glucose regulation", "peripheral tissues", "healthcare provider", "cardiovascular events", "comprehensive control", "combination medication", "dipeptidyl peptidase-4", "thiazolidinedione class", "cardiovascular benefits", "high blood sugar levels", "Cardioprotective Effects", "overall glycemic control", "type 2 diabetes mellitus", "meal) blood sugar levels", "Enhanced Insulin Sensitivity", "Incretin Hormone Enhancement", "inadequate insulin production", "Comprehensive Glycemic Control", "glucose-dependent insulinotropic peptide" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1480, "imageuri": "https://productimages.withfloats.com/actual/6661ad34c749b7962dbc4345.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661ad34c749b7962dbc4345.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:36:01.592Z", "updatedon": "2024-06-28T12:39:29.014Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/teneligold-pio-20-15-/1480", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TENELIGOLD PIO 20/15 ", "category": "DIABETIC RANGE", "tags": [ "TENELIGOLD PIO 20/15", "Teneligliptin", "Pioglitazone", "Teneligliptin uses", "Teneligliptin side effects", "Teneligliptin 20mg", "Teneligliptin+Metformin", "Teneligliptin 20 mg price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66604960a743fd235821fba0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "IMEGLIMON 500 ", "description": "IMEGLIMON 500 \nImeglimin Hydrochloride 500 mg\nIntroduction to IMEGLIMON 500\nIMEGLIMON 500 contains Imeglimin Hydrochloride 500mg, a novel oral medication used for the management of type 2 diabetes mellitus. Imeglimin represents a new class of oral antidiabetic agents known as \"glimins,\" which target multiple pathways involved in glucose metabolism. This medication helps improve blood sugar control by enhancing insulin sensitivity, increasing insulin secretion, and improving mitochondrial function.\n\nWhat is Imeglimin?\nOverview of Imeglimin\nImeglimin is an innovative oral antidiabetic agent that works through a multifaceted mechanism to improve glycemic control in patients with type 2 diabetes. Unlike traditional antidiabetic medications, Imeglimin targets multiple defects associated with type 2 diabetes, providing a comprehensive approach to managing blood sugar levels.\n\nMechanism of Action\nInsulin Sensitization: Imeglimin enhances insulin sensitivity in muscle and liver tissues, leading to improved glucose uptake and utilization.\nInsulin Secretion: It increases insulin secretion in response to glucose, helping to maintain more stable blood sugar levels.\nMitochondrial Function: Imeglimin improves mitochondrial function, which helps to reduce oxidative stress and improve overall cellular energy metabolism.\nBenefits of IMEGLIMON 500\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: IMEGLIMON 500 helps regulate both postprandial (after-meal) and fasting blood glucose levels by improving insulin sensitivity and secretion.\nComprehensive Glycemic Control: The unique mechanism of action of Imeglimin addresses multiple pathways involved in glucose metabolism, providing comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: IMEGLIMON 500 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, IMEGLIMON 500 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nImproved Mitochondrial Function: The positive effects on mitochondrial function can lead to reduced oxidative stress and improved overall cellular health.\nWeight Management: Imeglimin has a neutral effect on body weight, making it a suitable option for patients concerned about weight gain associated with some antidiabetic medications.\nHow to Use IMEGLIMON 500\nDosage and Administration\nRecommended Dosage: The typical dosage of IMEGLIMON 500 is one tablet taken twice daily, with meals. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to enhance absorption and reduce the risk of gastrointestinal discomfort. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take IMEGLIMON 500 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/imeglimon-500-134379", "price": 159.0, "discountamount": 47.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "Diet", "EMAIL", "Order", "water", "meals", "Action", "muscle", "option", "glimins", "Support", "patients", "readings", "Overview", "new class", "IMEGLIMON", "one tablet", "absorption", "Guidelines", "full glass", "neuropathy", "Optimal Use", "utilization", "body weight", "weight gain", "retinopathy", "Adjustments", "information", "Postprandial", "Reduced Risk", "sterispharma", "Introduction", "best results", "sterisonline", "CALL/WHATSAPP", "liver tissues", "Administration", "glucose uptake", "Consistent Use", "neutral effect", "treatment plan", "typical dosage", "positive effects", "multiple defects", "unique mechanism", "Exercise Adjunct", "oxidative stress", "Weight Management", "multiple pathways", "excellent adjunct", "insulin secretion", "glucose metabolism", "Recommended Dosage", "Diabetes Management", "blood sugar control", "insulin sensitivity", "individual response", "healthcare provider", "blood glucose levels", "Insulin Sensitization", "novel oral medication", "multifaceted mechanism", "cardiovascular disease", "comprehensive approach", "mitochondrial function", "overall cellular health", "Fasting Glucose Control", "lifestyle modifications", "Imeglimin Hydrochloride", "long-term complications", "type 2 diabetes mellitus", "oral antidiabetic agents", "stable blood sugar levels", "Additional Health Benefits", "gastrointestinal discomfort", "Comprehensive Glycemic Control", "Effective Blood Sugar Management", "overall cellular energy metabolism", "innovative oral antidiabetic agent", "traditional antidiabetic medications", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1375, "imageuri": "https://productimages.withfloats.com/actual/66604962487c46164ce29d69.png", "tileimageuri": "https://productimages.withfloats.com/tile/66604962487c46164ce29d69.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T11:17:52.343Z", "updatedon": "2024-06-29T12:01:46.362Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/imeglimon-500-/1375", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IMEGLIMON 500 ", "category": "DIABETIC RANGE", "tags": [ "IMEGLIMON 500", "Imeglimin Hydrochloride 500 mg", "Imeglimin hydrochloride 500 mg uses", "Imeglimin 500 Uses in Hindi", "Imeglimin 500 price", "Imeglimin hydrochloride tablets 1000mg", "Imeglimin side effects", "Imeglimin dose" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }